NKG2DL are membrane‐bound proteins expressed on tumor cell surfaces that are recognized by NKG2D receptors on NK cells and CD8+ T cells, mediating cytotoxic immune recognition, independent of tumor‐specific antigens. This evidence concerns the gene CD8A and neoplasm.